U.S. Physical Therapy, Inc.
$75.72
▼
-0.89%
2026-04-21 10:04:00
www.usph.com
NYQ: USPH
Explore U.S. Physical Therapy, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$431.66 M
Current Price
$75.72
52W High / Low
$93.5 / $64.99
Stock P/E
28.66
Book Value
$31.5
Dividend Yield
2.43%
ROCE
7.55%
ROE
7.59%
Face Value
—
EPS
$1.42
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
4,653
Beta
1.35
Debt / Equity
40.92
Current Ratio
1.01
Quick Ratio
1.01
Forward P/E
23.09
Price / Sales
1.5
Enterprise Value
$1.73 B
EV / EBITDA
16.77
EV / Revenue
2.24
Rating
Buy
Target Price
$104
EPS Forecast (FY)
—
Pros
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AMN Healthcare Services, Inc. | $20.46 | — | $790.91 M | — | 2.19% | -14.19% | $23.74 / $14.87 | $16.7 |
| 2. | Cross Country Healthcare, Inc. | $9.96 | — | $317.69 M | — | -1.05% | -25.57% | $14.99 / $7.43 | $10.18 |
| 3. | Tenet Healthcare Corporation | $189.93 | 12.26 | $16.56 B | — | 13.64% | 27.02% | $247.21 / $109.82 | $48.53 |
| 4. | Chemed Corporation | $385.77 | 19.4 | $5.15 B | 0.62% | 27.27% | 25.28% | $593.8 / $365.2 | $71.44 |
| 5. | LifeStance Health Group, Inc. | $6.92 | 277.93 | $2.69 B | — | 1.24% | 0.65% | $8.09 / $3.74 | $3.92 |
| 6. | AirSculpt Technologies, Inc. | $2.64 | — | $180.6 M | 0% | -0.99% | -14.06% | $12 / $1.51 | $1.36 |
| 7. | COMPASS Pathways plc | $9.46 | — | $639.93 M | — | 468.11% | -5.65% | $8.9 / $2.25 | $-0.55 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 202.73 M | 197.13 M | 197.34 M | 183.79 M | 180.45 M | — |
| Operating Profit | 22.01 M | 19.46 M | 24.15 M | 14.82 M | 16.96 M | — |
| Net Profit | -10.55 M | 5.22 M | 7.59 M | 12.8 M | 7.44 M | — |
| EPS in Rs | -0.7 | 0.35 | 0.5 | 0.85 | 0.49 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 780.99 M | 671.35 M | 604.8 M | 553.14 M |
| Operating Profit | 80.43 M | 65.63 M | 70.02 M | 65.91 M |
| Net Profit | 15.06 M | 26.46 M | 14.67 M | 28.27 M |
| EPS in Rs | 1 | 1.75 | 0.97 | 1.87 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.2 B | 1.17 B | 997.24 M | 858.15 M |
| Total Liabilities | 433.81 M | 408.42 M | 345 M | 373.59 M |
| Equity | 476.43 M | 488.93 M | 476.19 M | 315.79 M |
| Current Assets | 139.99 M | 137.58 M | 233.38 M | 111.27 M |
| Current Liabilities | 139.04 M | 116.28 M | 102.19 M | 85.49 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 75.06 M | 74.94 M | 81.98 M | 58.54 M |
| Investing CF | -36.71 M | -149.45 M | -45.02 M | -81.27 M |
| Financing CF | -44.14 M | -36.95 M | 84.27 M | 25.76 M |
| Free CF | 60.99 M | 65.75 M | 72.68 M | 50.29 M |
| Capex | -14.07 M | -9.19 M | -9.29 M | -8.25 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11% | 9.34% | — | — |
| Earnings Growth % | 80.32% | -48.09% | — | — |
| Profit Margin % | 3.94% | 2.43% | 5.11% | — |
| Operating Margin % | 9.78% | 11.58% | 11.92% | — |
| Gross Margin % | 18.46% | 20.09% | 20.25% | — |
| EBITDA Margin % | 12.94% | 12.3% | 13.76% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-13 | $0.46 |
| 2025-11-17 | $0.45 |
| 2025-08-22 | $0.45 |
| 2025-05-23 | $0.45 |
| 2025-03-14 | $0.45 |
Stock Splits
No stock split history available.